The European Parliament’s rapporteurs for the draft European Union legislation on pharmacovigilance and counterfeit medicines have amended the proposals to put more emphasis on the need to ensure the protection of public health.
Part of the “pharmaceutical package” of draft legislation produced by the European Commission at the end of 2008, the two proposals are due to be examined by the parliament’s environment and public health committee today1...
Please login to read the full article.
